Placental histopathologic features in patients with thrombophilic mutations

References

• Clark P, Brennand J, Conkie J A, McCall F, Green I A, Walker I D. Activated protein C sensitivity, protein C, protein S, and coagulation in normal pregnancy. Thromb Haemost 1998; 79: 1166–1170
   PubMed Web of Science ®Google Scholar
• McColl M D, Walker I D, Greer I A. The role of inherited thrombophilia in venous thromboembolism associated with pregnancy. Br J Obstet Gynaecol 1999; 106: 756–766
   PubMedGoogle Scholar
• Lane D A, Bayston T, Olds R J, Fitches A C, Cooper D N, Miller D S, Jochmans K, Perry D J, Okajima K, Thein S L, Emmerich J. Antithrombin mutation database: 2nd update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1997; 77: 197–211
   PubMed Web of Science ®Google Scholar
• Kupferminc M J, Fait G, Many A, Gordon D, Eldor A, Lessing J B. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000; 96: 45–49
   PubMed Web of Science ®Google Scholar
• Kupferminc M J, Rimon E, Asher-Landsberg J, Lessino J B, Many A. Perinatal outcome in women with severe pregnancy complications and multiple thrombophilias. J Perinat Med 2004; 32: 225–227
   PubMedGoogle Scholar
• Van Pampus M G, Dekker G A, Wolf H, Huijgens P C, Koopman M M, Von Blomberg B M, Buller H R. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol 1999; 180: 1146–1150
   PubMed Web of Science ®Google Scholar
• Von Tempelhoff G F, Heilmann L, Spanuth E, Kunzmann E, Hommel G. Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-syndrome. Hemolysis, elevated liver-enzymes, low platelets. Thromb Res 2000; 100: 363–365
   PubMed Web of Science ®Google Scholar
• Kupferminc M J, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fair C, Lessino J B. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9–13
   PubMed Web of Science ®Google Scholar
• Kupferminc M J, Many A, Bar-Am A, Lessing J B, Ascher-Landsberg J. Mid-trimester severe intrauterine growth restriction is associated with a prevalence of thrombophilia. BJOG 2002; 109: 1373–1376
   PubMed Web of Science ®Google Scholar
• Van der Molen E F, Verbruggen B, Novakova I, Eskes T S, Monnens L A, Blom H J. Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy. BJOG 2000; 107: 785–791
   PubMed Web of Science ®Google Scholar
• Wiener-Megnagi Z, Ben-Shlomo I, Goldberg Y, Shalev E. Resistance to activate protein C and the Leiden mutation: High prevalence in patients with abruptio placentae. Am J Obstet Gynecol 1998; 179: 1565–1567
   PubMed Web of Science ®Google Scholar
• Arias F, Romero R, Joist H, Kraus F T. Thrombophilia: A mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med 1998; 7: 277–286
   PubMedGoogle Scholar
• Gharavi A E, Pierangeli S S, Levy R A, Harris E N. Mechanisms of pregnancy loss in antiphospholipid syndrome. Clin Obstet Gynecol 2001; 44: 11–19
   PubMed Web of Science ®Google Scholar
• Gris J C, Ripart-Neveu S, Maugard C, Tailland M L, Brun S, Courtieu C, Biron C, Hoffet M, Hedon B, Mares P. Retrospective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) study. Thromb Haemost 1997; 77: 1096–1103
   PubMed Web of Science ®Google Scholar
• Many A, Elad R, Yaron Y, Eldon A, Lessing J B, Kupferminc M J. Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia. Obstet Gynecol 2002; 99: 684–687
   PubMed Web of Science ®Google Scholar
• Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa M V, Bozzo M, Mannucci P M. Mutations in coagulation factors in woman with unexplained late fetal loss. New Engl J Med 2000; 343: 1015–1018
   PubMed Web of Science ®Google Scholar
• Preston F E, Rosendaal F R, Walzer I D, Briet E, Berntorp E, Canard J, Fontcuberta J, Makris M, Mariani G, Noteboom W. Increased fetal loss in women with heritable thrombophilia. Lancet 1996; 348: 913–916
   PubMed Web of Science ®Google Scholar
• Rey E, Kahn S R, David M, Shrier I. Thrombophilic disorders and fetal loss: A meta-analysis. Lancet 2003; 361: 901–908
   PubMed Web of Science ®Google Scholar
• Roque H, Paidas M J, Funai E F, Kuczynski E, Lockwood C J. Maternal thrombophilias are not associated with early pregnancy loss. Thromb Haemost 2004; 91: 290–295
   PubMed Web of Science ®Google Scholar
• Sarig G, Younis J S, Hoffman R, Lanir N, Blumenfeld Z, Brenner B. Thrombophilia is common in women with idiopathic pregnancy loss and it is associated with late pregnancy wastage. Fertil Steril 2002; 77: 342–347
   PubMed Web of Science ®Google Scholar
• Klurfeld D M. Identification of foam cells in human atherosclerotic lesions as macrophages using monoclonal antibodies. Arch Pathol 1985; 109: 445–449
   Google Scholar
• Benirschke K, Kaufmann P, Baerger R. Pathology of the human placenta5^th ed. Springer, New York 2006
   Google Scholar
• Rand J H, Wu X X, Andree H A, Lockwood C J, Guller S, Scher J, Harpel P C. Pregnancy loss in the antiphospholipid-antibody syndrome—a possible thrombogenic mechanism. N Engl J Med 1997; 337: 154–160
   PubMed Web of Science ®Google Scholar
• Many A, Schreiber L, Rosner S, Lessing J B, Eldor A, Kupferminc M J. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol 2001; 98: 1041–1044
   PubMed Web of Science ®Google Scholar
• Faye-Petersen O M, Heller D S, Joshi V V. Lesion of the chorionic villi involving the trophoblast. Handbook of placental pathology2^nd ed. Taylor & Francis, LondonUK 2006
   Google Scholar
• Kauffman P, Scheffen I. Placental development. Neonatal and fetal medicine—physiology and pathophysiology, R A Polin, W W Fox. Saunders, OrlandoUSA 1992; I: 47–55
   Google Scholar
• Kupferminc M J. Thrombophilia and preeclampsia: The evidence so far. Clin Obstet Gynecol 2005; 48: 406–415
   PubMedGoogle Scholar
• Mandsager N T, Bendon R, Mostello D, Rosen B, Miodovnik M, Siddiqi T A. Maternal floor infarction of the placenta: Prenatal diagnosis and clinical significance. Obstet Gynecol 1994; 83: 750–754
   PubMed Web of Science ®Google Scholar
• Katz V L, DiTomasso J, Farmer R, Carpenter M. Activated protein C resistance associated with maternal floor infarction treated with low-molecular-weight heparin. Am J Perinatol 2002; 19: 273–277
   PubMed Web of Science ®Google Scholar
• Sebire N J, Backos M, Golden R D, Regan L. Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. BJOG 2002; 109: 570–573
   PubMed Web of Science ®Google Scholar
• Katz V L, Bowes W A, Sierkh A E. Maternal floor infarction of the placenta associated with elevated second trimester alpha fetoprotein. Am J Perinatol 1987; 4: 225–228
   PubMedGoogle Scholar
• Fox H. Thrombosis of the foetal arteries in the human placenta. J Obstet Gynaecol Br Commonw 1966; 73: 961–965
   PubMedGoogle Scholar
• Gruenwald P. Abnormalities of placental vascularity in relation to intrauterine deprivation and retardation of fetal growth: Significance of avascular chorionic villi. NY State J Med 1961; 61: 1508–1513
   PubMedGoogle Scholar
• Redline R W, Pappin A. Fetal thrombotic vasculopathy: The clinical significance of extensive avascular villi. Human Pathol 1995; 26: 80–85
   PubMed Web of Science ®Google Scholar
• Sander C M, Gilliland D, Akers C, McGrath A, Bismar T A, Swart-Hills L A. Livebirths with placental hemorrhagic endovasculitis: Interlesional relationships and perinatal outcomes. Arch Pathol Lab Med 2002; 126: 157–164
   PubMedGoogle Scholar
• Sander C M. Hemorrhagic endovasculitis in the placenta. Am J Obstet Gynecol 1992; 167: 1483
   PubMedGoogle Scholar
• Roberts D J, Oliva E. Clinical significance of placental examination in perinatal medicine. J Matern Fetal Neonatal Med 2006; 19: 255–264
   PubMed Web of Science ®Google Scholar
• Redline R W, Ariel I, Baergen R N, Desa D J, Kraus F T, Roberts D J, Sander C M, the Society for Pediatric Pathology, Perinatal Section, Fetal Vascular Obstruction Nosology Committee. Fetal vascular obstructive lesions: Nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004; 7: 443–452
   PubMed Web of Science ®Google Scholar
• Redline R W, O'Riordan M A. Placental lesions associated with cerebral palsy and neurological impairment following term birth. Arch Pathol Lab Med 2000; 124: 1785–1791
   PubMed Web of Science ®Google Scholar
• Sander C H. Hemorrhagic endovasculitis and hemorrhagic villitis of the placenta. Arch Pathol Lab Med 1980; 104: 371–373
   PubMedGoogle Scholar
• Sander C H, Kinnane L, Steven N G, Echt R. Hemorrhagic endovasculitis of the placenta: A review with clinical correlation. Placenta 1986; 7: 551–574
   PubMedGoogle Scholar
• Sander C H, Steven N G. Hemorrhagic endovasculitis of the placenta: An in-depth morphologic appraisal with initial clinical and epidemiologic observations. Pathol Annu 1984; 19: 37–79
   PubMedGoogle Scholar
• Debus O, Koch H G, Kurlemann G, Strater R, Vielhaber H, Weber P, Nowak-Gottl U. Factor V Leiden and genetic defects of thrombophilia in childhood porencephaly. Arch Dis Child Fetal Neonatal Ed 1998; 78: F121–F124
   Google Scholar
• Van Allen M I, Jackson J C, Knopp R H, Cone R. In utero thrombosis and neonatal gangrene in an infant of a diabetic mother. Am J Med Genet 1989; 33: 323–327
   PubMedGoogle Scholar
• Redline R W. Clinical and pathological umbilical cord abnormalities in fetal thrombotic vasculopathy. Hum Pathol 2004; 35: 1494–1498
   PubMed Web of Science ®Google Scholar
• Dahms B B, Boyd T, Redline R W. Severe perinatal liver disease associated with fetal thrombotic vasculopathy. Pediatr Dev Pathol 2002; 5: 80–85
   PubMedGoogle Scholar
• Redline R W, Shah D, Saker H, Schluchter M, Salvator A. Placental lesions associated with abnormal growth in twins. Pediatr Dev Pathol 2001; 4: 473–481
   PubMed Web of Science ®Google Scholar
• Kraus F T, Acheen V I. Fetal thrombotic vasculopathy in the placenta: Cerebral thrombi and infarcts, coagulopathies, and cerebral palsy. Hum Pathol 1999; 30: 759–769
   PubMed Web of Science ®Google Scholar
• Brenner B. Inherited thrombophilia and fetal loss. Curr Opin Hematol 2000; 7: 290–295
   PubMed Web of Science ®Google Scholar
• Kupferminc M J, Fait G, Many A, Gordon D, Eldor A, Lessing J B. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000; 96: 45–49
   PubMed Web of Science ®Google Scholar
• Salafia C M, Ernst L M, Pezzullo J C, Wolf E J, Rosenkrantz T S, Vintzileos A M. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: Associated placental pathologic features. Am J Obstet Gynecol 1995; 173: 1049–1057
   PubMed Web of Science ®Google Scholar
• Redline R W, Patterson P. Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells. Am J Pathol 1993; 143: 473–479
   PubMed Web of Science ®Google Scholar
• Sikkema J M, Franx A, Bruinse H W, van der Wijk N G, Nikkels P GJ. Placental pathology in early onset pre-eclampsia and intra-uterine growth restriction in women with and without thrombophilia. Placenta 2002; 23: 337–342
   PubMed Web of Science ®Google Scholar
• Van Horn J T, Crafen C, Ward K, Branch D W, Silver R M. Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes. Placenta 2004; 25: 642–648
   PubMed Web of Science ®Google Scholar
• Morssink L P, Santema J G, Willemse F. Thrombophilia is not associated with an increase in placental abnormalities in women with intra-uterine fetal death. Acta Obstet Gynecol Scand 2004; 83: 348–350
   PubMedGoogle Scholar
• Mousa H A, Alfirevic Z. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?. Hum Reprod 2000; 15: 1830–1833
   PubMed Web of Science ®Google Scholar
• Khong T Y, Moore L, Hague W M. Thrombophilia and adverse pregnancy outcome. Hum Reprod 2000; 15: 1830–1833
   PubMedGoogle Scholar
• Hustin J, Jauniaux E, Schaaps J P. Histological study of the materno-embryonic interface in spontaneous abortion. Placenta 1990; 11: 477–486
   PubMed Web of Science ®Google Scholar
• Sebire N J, Fox H, Backos M, Rai R, Paterson C, Regan L. Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod 2002; 17: 1067–1071
   PubMed Web of Science ®Google Scholar
• Hubel C A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999; 222: 222–235
   PubMed Web of Science ®Google Scholar
• Redman C W, Sargent I L. Placental debris, oxidative stress and pre-eclampsia. Placenta 2000; 21: 597–602
   PubMed Web of Science ®Google Scholar
• Roberts J M, Hubel C A. Is oxidative stress the link in the two-stage model of pre-eclampsia?. Lancet 1999; 354: 788–789
   PubMed Web of Science ®Google Scholar
• Hempstock J, Jauniaux E, Greenwold N, Burton G J. The contribution of placental oxidative stress to early pregnancy failure. Hum Pathol 2003; 34: 1265–1275
   PubMed Web of Science ®Google Scholar
• Jauniaux E, Hempstock J, Greenwold N, Burton G J. Trophoblast oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal pregnancies. Am J Pathol 2003; 162: 115–125
   PubMed Web of Science ®Google Scholar
• Vincent T, Rai R, Regan L, Cohen H. Increased thrombin generation in women with recurrent miscarriage. Lancet 1998; 352: 116
   PubMed Web of Science ®Google Scholar
• Laude I, Rongieres-Bertrand C, Boyer-Neumann C, Wolf M, Mairovitz V, Hugel B, Freyssinet J M, Frydman R, Meyer D, Eschwege V. Circulating procoagulant microparticles in women with unexplained pregnancy loss: A new insight. Thromb Haemost 2001; 85: 18–21
   PubMed Web of Science ®Google Scholar
• Kwak J Y, Beer A E, Kim S H, Mantouvalos H P. Immunopathology of the implantation site utilizing monoclonal antibodies to natural killer cells in women with recurrent pregnancy losses. Am J Reprod Immunol 1999; 41: 91–98
   PubMedGoogle Scholar
• Laird S M, Tuckerman E M, Cork B A, Linjawi S, Blakemore A I, Li T C. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update 2003; 9: 163–174
   PubMed Web of Science ®Google Scholar
• Giordano P, Laforgia N, Di Giulio G, Storelli S, Mautone A, Iolascon A. Renal vein thrombosis in a newborn with prothrombotic genetic risk factors. J Perinat Med 2001; 29: 163–167
   PubMedGoogle Scholar
• Grow J L, Fliman P J, Pipe S W. Neonatal sinovenous thrombosis associated with homozygous thermolabile methylenetetrahydrofolate reductase in both mother and infant. J Perinatol 2002; 22: 175–178
   PubMedGoogle Scholar
• Khong T Y, Hague W M. Biparental contribution to fetal thrombophilia in discordant twin intrauterine growth restriction. Am J Obstet Gynecol 2001; 185: 244–245
   PubMedGoogle Scholar
• Stanec J, Bove K E, Bofinger M, Needham D, Saldana L R, Mutema G K, Meyer R. Premature closure of foramen ovale and renal vein thrombosis in a stillborn twin homozygous for methylene tetrahydrofolate reductase gene polymorphism: A clinicopathologic study. J Perinat Med 2000; 28: 61–68
   PubMedGoogle Scholar
• Ariel I, Anteby E, Hamani Y, Redline R W. Placental pathology in fetal thrombophilia. Hum Pathol 2004; 35: 729–733
   PubMed Web of Science ®Google Scholar
• Gonen R, Lavi N, Attias D, Schliamser L, Borochowitz Z, Toubi E, Ohel G. Absence of association of inherited thrombophilia with unexplained third-trimester intrauterine fetal death. Am J Obstet Gynecol 2005; 192: 742–746
   PubMedGoogle Scholar
• Vern T Z, Alles A J, Kowal-Vern A, Longtine J, Roberts D J. Frequency of factor V (Leiden) and prothrombin G20210A in placentas and their relationship with placental lesions. Hum Pathol 2000; 31: 1036–1043
   PubMed Web of Science ®Google Scholar
• Dizon-Townson D S, Miller C, Sibai B, Spong C Y, Thom E, Wendel G, Jr, Wenstrom K, Samuel P, Cotroneo M A, Moawad A, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005; 106: 517–524
   PubMed Web of Science ®Google Scholar
• Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314: 253–257
   PubMed Web of Science ®Google Scholar
• Fowler J M, Ramirez N, Cohn D E, Kelbick N, Pavelka J, Ben Shachar I. Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: Tissue microarray analysis. Am J Obstet Gynecol 2005; 192: 1262–1271
   PubMedGoogle Scholar
• Nocito A, Bubendorf L, Tinner E M, Suess K, Wagner U, Forster T, Kononen J, Fijan A, Bruderer J, Schmid U, et al. Microarray of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 2001; 194: 349–357, (Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Anabitarte M, Hering F, Hardmeier T, Schoenenberger AJ, Flury R, Jager P, Fehr JL, Schraml P, Moch H, Mihatsch MJ, Gasser T, Sauter G)
   PubMed Web of Science ®Google Scholar
• Sallinen S L, Sallinen P K, Haapasalo H K, Helin H J, Helen P T, Schraml P, Kallioniemi O P, Kononen J. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res 2000; 60: 6617–6622
   PubMed Web of Science ®Google Scholar